RS87004A - Process for preparing a finely self- emulsifiable pharmaceutical composition - Google Patents

Process for preparing a finely self- emulsifiable pharmaceutical composition

Info

Publication number
RS87004A
RS87004A YU87004A YUP87004A RS87004A RS 87004 A RS87004 A RS 87004A YU 87004 A YU87004 A YU 87004A YU P87004 A YUP87004 A YU P87004A RS 87004 A RS87004 A RS 87004A
Authority
RS
Serbia
Prior art keywords
preparing
pharmaceutical composition
pharmaceutically acceptable
composition
emulsifiable
Prior art date
Application number
YU87004A
Other languages
English (en)
Inventor
Ping Gao
Xiaorong He
Keith Bolyard
Original Assignee
Pharmacia Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corporation filed Critical Pharmacia Corporation
Publication of RS87004A publication Critical patent/RS87004A/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

Data je oralno primenljiva kompozicija koja sadrži lek slabo rastvorljiv u vodi i tečnost rastvarača koja sadrži najmanje jedan farmaceutski prihvatljiv rastvarač, najmanje jednu farmaceutski prihvatljivu masnu kiselinu i najmanje jedan farmaceutski prihvatljivi organski amin, gde (a) značajan deo, na primer najmanje 15% po težini, leka je u rastopljenom ili rastvorenom obliku u tečnosti rastvarača i (b) masna kiselina i organski amin su prisutni u takvim ukupnim i relativnim količinama da je kompozicija fino samoemulzifikujuća u simuliranoj želudačnoj tečnosti. Obezbeđen je takođe i postupak za pripremanje takve kompozicije.
YU87004A 2002-04-09 2003-04-07 Process for preparing a finely self- emulsifiable pharmaceutical composition RS87004A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37120002P 2002-04-09 2002-04-09
PCT/US2003/010526 WO2003086392A2 (en) 2002-04-09 2003-04-07 Process for preparing a finely self-emulsifiable pharmaceutical composition

Publications (1)

Publication Number Publication Date
RS87004A true RS87004A (en) 2006-12-15

Family

ID=29250656

Family Applications (1)

Application Number Title Priority Date Filing Date
YU87004A RS87004A (en) 2002-04-09 2003-04-07 Process for preparing a finely self- emulsifiable pharmaceutical composition

Country Status (19)

Country Link
US (1) US20030235596A1 (sr)
EP (1) EP1492527B1 (sr)
JP (1) JP2005529104A (sr)
KR (1) KR100779285B1 (sr)
CN (1) CN1305470C (sr)
AT (1) ATE410162T1 (sr)
AU (1) AU2003223485B2 (sr)
BR (1) BR0309138A (sr)
CA (1) CA2481677A1 (sr)
DE (1) DE60323953D1 (sr)
ES (1) ES2310653T3 (sr)
HK (1) HK1076382A1 (sr)
IL (1) IL164163A0 (sr)
MX (1) MXPA04009880A (sr)
PL (1) PL372807A1 (sr)
RS (1) RS87004A (sr)
RU (1) RU2299061C2 (sr)
WO (1) WO2003086392A2 (sr)
ZA (1) ZA200407711B (sr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10211801B4 (de) 2002-03-16 2004-09-30 Clariant Gmbh Kosmetische und pharmazeutische Zubereitungen enthaltend einen oxalkylierten Polyglycerinester
US9498454B2 (en) 2003-02-24 2016-11-22 Pharmaceutical Productions Inc. Transmucosal drug delivery system
CA2516816C (en) * 2003-02-24 2012-02-07 Pharmaceutical Productions, Inc. Transmucosal drug delivery system
US9254294B2 (en) 2003-02-24 2016-02-09 Pharmaceutical Productions Inc. Transmucosal hormone delivery system
US9358296B2 (en) 2003-02-24 2016-06-07 Pharmaceutical Productions Inc. Transmucosal drug delivery system
JP2006232755A (ja) * 2005-02-25 2006-09-07 Dai Ichi Kogyo Seiyaku Co Ltd 油中水型マイクロエマルション
US8333989B2 (en) * 2005-10-26 2012-12-18 Banner Pharmacaps, Inc. Hydrophilic vehicle-based dual controlled release matrix system
CN101351196B (zh) 2005-10-26 2013-07-03 班纳制药公司 作为胶囊填充物的基于亲脂性载体的双重控释基质系统
JP5600058B2 (ja) * 2007-04-11 2014-10-01 ファーマシューティカル プロダクションズ， インコーポレイテッド メラトニンタブレットならびに調剤及び使用方法
WO2011047259A1 (en) 2009-10-16 2011-04-21 Glaxosmithkline Llc Compositions
CA2785251A1 (en) * 2009-12-22 2011-06-30 Leo Pharma A/S Cutaneous composition comprising vitamin d analogue and a mixture of solvent and surfactants
AT511045A1 (de) 2011-01-28 2012-08-15 Blum Gmbh Julius Möbelteil mit einer drehmomentübertragenden welle
US8951514B2 (en) 2011-02-16 2015-02-10 Pivotal Therapeutics Inc. Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels
US8952000B2 (en) 2011-02-16 2015-02-10 Pivotal Therapeutics Inc. Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events
US9119826B2 (en) 2011-02-16 2015-09-01 Pivotal Therapeutics, Inc. Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels
HRP20211377T1 (hr) 2011-11-23 2022-01-07 Therapeuticsmd, Inc. Prirodne kombinirane hormonske supstitucijske formulacije i terapije
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
CN103965113A (zh) * 2014-05-06 2014-08-06 四川大学 1-羟乙基-2-取代苯氧甲基苯并咪唑类化合物及其制备方法
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
US11400048B2 (en) 2014-06-25 2022-08-02 Synergia Bio Sciences Private Limited Pharmaceutical oil-in-water nano-emulsion
WO2015198350A1 (en) 2014-06-25 2015-12-30 Synergia Bio Sciences Private Limited A pharmaceutical oil-in-water nano-emulsion
US10098894B2 (en) 2014-07-29 2018-10-16 Therapeuticsmd, Inc. Transdermal cream
CN117547528A (zh) 2015-05-28 2024-02-13 瑞迪博士实验室有限公司 用于治疗疼痛的塞来昔布口服组合物
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
CN105343002B (zh) * 2015-11-27 2019-07-26 济南康和医药科技有限公司 一种依托考昔口服微乳制剂及其制备方法
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
AU2017239645A1 (en) 2016-04-01 2018-10-18 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
CN111729125B (zh) * 2020-07-31 2022-10-04 陕西佰傲再生医学有限公司 骨止血材料
CN114681470A (zh) * 2020-12-28 2022-07-01 雷迪博士实验室有限公司 治疗疼痛的方法
CN113750043A (zh) * 2021-09-18 2021-12-07 山东省药学科学院 一种塞来昔布自乳化口服液及其制备方法
KR102635930B1 (ko) 2021-10-29 2024-02-14 단국대학교 천안캠퍼스 산학협력단 자가나노유화 약물전달시스템을 이용한 셀레콕시브 함유 경구 투여용 제제 및 이의 제조방법
GB2616663A (en) 2022-03-18 2023-09-20 Alkaloid Ad Skopje Pharmaceutical formulation

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2385389A1 (fr) * 1977-03-29 1978-10-27 Capsugel Ag Capsule emboitee remplie d'une matiere visqueuse telle que, notamment, une preparation pharmaceutique liquide
JP2564889B2 (ja) * 1988-03-07 1996-12-18 松下電工株式会社 軸流フアン
US5264223A (en) * 1990-03-29 1993-11-23 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5466823A (en) * 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
US5756123A (en) * 1994-12-01 1998-05-26 Japan Elanco Co., Ltd. Capsule shell
US5633272A (en) * 1995-02-13 1997-05-27 Talley; John J. Substituted isoxazoles for the treatment of inflammation
US5981576A (en) * 1995-10-13 1999-11-09 Merck Frosst Canada, Inc. (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors
US5993858A (en) * 1996-06-14 1999-11-30 Port Systems L.L.C. Method and formulation for increasing the bioavailability of poorly water-soluble drugs
US5861419A (en) * 1996-07-18 1999-01-19 Merck Frosst Canad, Inc. Substituted pyridines as selective cyclooxygenase-2 inhibitors
US6034256A (en) * 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation
CN1227003C (zh) * 1998-09-09 2005-11-16 阿尔萨公司 包括液体制剂的剂型
MY120279A (en) * 2000-05-26 2005-09-30 Pharmacia Corp Use of a celecoxib composition for fast pain relief
TWI232761B (en) * 2000-07-01 2005-05-21 Pharmaceutical Ind Tech & Dev Capsule preparation for oral administration and the preparation method thereof
US20020077328A1 (en) * 2000-07-13 2002-06-20 Fred Hassan Selective cyclooxygenase-2 inhibitors and vasomodulator compounds for generalized pain and headache pain
US20030105141A1 (en) * 2001-04-17 2003-06-05 Ping Gao Finely self-emulsifiable pharmaceutical composition

Also Published As

Publication number Publication date
ES2310653T3 (es) 2009-01-16
WO2003086392A2 (en) 2003-10-23
DE60323953D1 (de) 2008-11-20
ATE410162T1 (de) 2008-10-15
RU2299061C2 (ru) 2007-05-20
HK1076382A1 (en) 2006-01-20
KR20070014237A (ko) 2007-02-01
BR0309138A (pt) 2005-02-01
IL164163A0 (en) 2005-12-18
RU2004130291A (ru) 2005-05-27
EP1492527A2 (en) 2005-01-05
AU2003223485A1 (en) 2003-10-27
WO2003086392A3 (en) 2004-03-25
CN1658870A (zh) 2005-08-24
ZA200407711B (en) 2006-06-28
EP1492527B1 (en) 2008-10-08
JP2005529104A (ja) 2005-09-29
MXPA04009880A (es) 2004-12-07
CA2481677A1 (en) 2003-10-23
KR100779285B1 (ko) 2007-11-28
CN1305470C (zh) 2007-03-21
US20030235596A1 (en) 2003-12-25
PL372807A1 (en) 2005-08-08
AU2003223485B2 (en) 2007-05-31

Similar Documents

Publication Publication Date Title
HK1076382A1 (en) Process for preparing a finely self-emulsifiable pharmaceutical composition
WO2002056878A3 (en) Pharmaceutical composition having reduced tendency for drug crystallization
CO5580835A2 (es) Nuevas formulaciones analogas de ciclosporina
NO20085078L (no) Nye forbindelser
EA200301019A1 (ru) Доставляемая перорально фармацевтическая композиция, включающая препарат с низкой растворимостью в воде (ингибитор cox-2), растворитель, жирную кислоту и органический амин
WO2005004917A3 (en) Pharmaceutical composition for solubility enhancement of hydrophobic drugs
BG106439A (en) Pharmaceutical composition of improved solubility and oral absorptivity, containing benzamide derivative
ES2110377T1 (es) Formulacion galenica de fenofibrato y aplicacion de la misma.
DE602004016856D1 (de) Hfc lösungsformulierungen enthaltend ein anticholinergikum
DE602004011966D1 (en) Heterocyclylverbindungen
PL338335A1 (en) Pharmaceutic composition in the of self-emulsifiable formulation of lipophilic compounds
NO20014718D0 (no) Formulering inneholdende testosteron-undekanoat og castorolje
DK0734383T3 (da) Cykliske amidderivater som neurokinin-A-antagonister
SV2002000301A (es) Composicion farmaceutica ref. z-1032
MA27576A1 (fr) Nouveaux derives d'azepines tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
NO950134L (no) Formuleringer for oralt administrerte farmasöytiske midler
ATE293635T1 (de) Streptograminderivate, ihre herstellung und sie enthaltende zubereitungen
IL164763A (en) Hyperforin derivatives, the use thereof and formulations containing them
WO2021076847A1 (en) Compositions comprising quinone and/or quinol and methods of preparations and use thereof
WO2001053322A3 (en) Aerothricin analogs, their preparation and use
ATE252598T1 (de) Streptograminderivate, ihre herstellung und sie enthaltende zubereitungen
TH40972B (th) สารประกอบอินทรีย์
IT1247030B (it) Forma microcristallina dell'acido meclofenamico, metodo e formulazioni farmaceutiche
BG106114A (en) Mastic and method for the preparation of a pharmaceutical form of paclitaxel